PHYSIOLOGY AND PATHOPHYSIOLOGY OF COMPLEMENT - PROGRESS AND TRENDS

被引:117
作者
MORGAN, BP
机构
[1] Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff
[2] University of British Columbia, Columbia, BC
基金
英国惠康基金;
关键词
COMPLEMENT; DISEASE; DEFICIENCIES; TRANSPLANTATION; THERAPY;
D O I
10.3109/10408369509084686
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The complement system comprises a family of at least 20 plasma and membrane proteins that interact in a tightly regulated cascade system to destroy invading bacteria and prevent the deposition of immune complexes in the tissues. This brief review addresses the basic mechanisms of complement activation and control and describes the active fragments produced during complement activation. The biological importance of the complement system is amply illustrated in patients with complement deficiencies, who are susceptible to bacterial infections and immune complex diseases. The involvement of complement in other immunological diseases is an expanding area of clinical research, supported by the development of new assays for the identification of complement activation. This area is discussed here with particular reference to neurological diseases. A promising new prospect involves the use of complement inhibitory molecules in therapy of complement-mediated disease and this exciting area is also discussed. Novel physiological roles of complement also are being revealed and new evidence that complement and complement receptors play an important role in reproduction is summarized. It is hoped that this brief overview will convey some of the enthusiasm currently pervading research in this underappreciated area of immunology.
引用
收藏
页码:265 / 298
页数:34
相关论文
共 215 条
[1]  
ASGHAR SS, 1984, PHARMACOL REV, V36, P223
[2]   PRIMING OF HUMAN NEUTROPHIL FUNCTIONS BY TUMOR-NECROSIS-FACTOR - ENHANCEMENT OF SUPEROXIDE ANION GENERATION, DEGRANULATION, AND CHEMOTAXIS TO CHEMOATTRACTANTS C5A AND F-MET-LEU-PHE [J].
BAJAJ, MS ;
KEW, RR ;
WEBSTER, RO ;
HYERS, TM .
INFLAMMATION, 1992, 16 (03) :241-250
[3]  
BARNUM SR, 1993, COMPLEMENT TODAY, V1, P76
[4]  
BHAKDI S, 1988, J IMMUNOL, V141, P3117
[5]   COMPLEMENT LYSIS - A HOLE IS A HOLE [J].
BHAKDI, S ;
TRANUMJENSEN, J .
IMMUNOLOGY TODAY, 1991, 12 (09) :318-320
[6]   COMPLEMENT-MEDIATED ENDOTHELIAL-CELL DAMAGE IN IMMUNE-COMPLEX VASCULITIS OF THE SKIN - ULTRASTRUCTURAL-LOCALIZATION OF THE MEMBRANE ATTACK COMPLEX [J].
BOOM, BW ;
MOMMAAS, M ;
DAHA, MR ;
VERMEER, BJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (02) :S68-S72
[7]  
Buchner H., 1889, ZENTRALBL BAKTERIOL, V6, P561
[8]   THE DEGRADATION PRODUCT OF THE C5A ANAPHYLATOXIN C5A(DESARG) RETAINS BASOPHIL-ACTIVATING PROPERTIES [J].
BURGI, B ;
BRUNNER, T ;
DAHINDEN, CA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) :1583-1589
[9]  
BURNET FM, 1969, CELL IMMUNOL, P160
[10]   AMINO-ACID-SEQUENCE AROUND THE THIOL AND REACTIVE ACYL-GROUPS OF HUMAN-COMPLEMENT COMPONENT-C4 [J].
CAMPBELL, RD ;
GAGNON, J ;
PORTER, RR .
BIOCHEMICAL JOURNAL, 1981, 199 (02) :359-370